The company based in California(CA)reported a fellin revenue to $25.82 milion for the year when compared to $57.03 million in the previous year.
A filing from the company with the Securities and Exchange Commission on Mar 17,2023 showed that its revenue is up 54.73% year-over-year.
The company reported basic earnings per share of $24619700 and diluted earnings per share of $24619700.
Tarsus Pharmaceuticals, Inc. operates in the
Biological Products, Except Diagnostic Substances sector.
Related News
